VUF11211

Item number	Size	Delivery time	Price
TGM-T23656-25mg	25 mg	7 - 10 business days*	1,440.00€
TGM-T23656-50mg	50 mg	7 - 10 business days*	1,877.00€
TGM-T23656-100mg	100 mg	7 - 10 business days*	2,371.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: VUF11211 is an effective antagonist of CXCR3 that acts by extending from the minor... more

Close menu

Product information "VUF11211"

Description: VUF11211 is an effective antagonist of CXCR3 that acts by extending from the minor pocket into the major pocket of the transmembrane domains. Target: Others. Smiles: C(C)[C@@H]1N(CCN(C1)C2=C(Cl)C=C(C(NCC)=O)C=N2)C3CCN(CC4=CC=C(Cl)C=C4)CC3. References: Ganghammer S, Gutjahr J, Hutterer E, Krenn PW, Pucher S, Zelle-Rieser C, Jöhrer K, Wijtmans M, Leurs R, Smit MJ, Gattei V, Greil R, Hartmann TN. Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors. Haematologica. 2016 Mar,101(3):e99-102. doi: 10.3324/haematol.2015.133470. Epub 2015 Nov 20. PubMed PMID: 26589908, PubMed Central PMCID: PMC4815737.

Keywords:	VUF 11211, VUF-11211
Supplier:	TargetMol
Supplier-Nr:	T23656

Properties

MW:	504.49 D
Formula:	C26H35Cl2N5O

Database Information

CAS :

906556-51-2| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "VUF11211"

Write a review